1. AB0446 Treatment Effects and Minimal Clinically Important Differences in Patient-Reported Outcomes Following Treatment and Withdrawal of Abatacept, Methotrexate Or Combination Therapy in Patients with Early Rheumatoid Arthritis. (9th June 2015) Authors: Furst, D.E.; Bykerk, V.P.; Burmester, G.R.; Combe, B.G.; Huizinga, T.W.J.; Alemao, E.; Wong, D.A.; Emery, P. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 1044 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. AB0469 Can Anti-TNF-Induced Autoantibody Conversion be Reversed by Switching to Abatacept Therapy in Patients with RA on Background MTX?. (9th June 2015) Authors: Buch, M.H.; Johnsen, A.; Wong, D.A.; Schiff, M. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 1053 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. FRI0152 On Drug and Drug-Free Remission by Baseline Disease Duration in the Avert Trial: Abatacept Versus Methotrexate Comparison in Patients with Early Rheumatoid Arthritis. (9th June 2015) Authors: Bykerk, V.P.; Burmester, G.R.; Combe, B.G.; Furst, D.E.; Huizinga, T.W.J.; Wong, D.A.; Emery, P. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 477 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. THU0114 Effect of Anti-Cyclic Citrullinated Peptide 2 Immunoglobulin M Serostatus on Efficacy Outcomes Following Treatment with Abatacept Plus Methotrexate in the Avert Trial. (9th June 2015) Authors: Huizinga, T.W.J.; Connolly, S.E.; Johnsen, A.; Zhu, J.; Furst, D.E.; Bykerk, V.P.; Burmester, G.R.; Combe, B.G.; Wong, D.A.; Trouw, L.A.; Toes, R.E.M.; Emery, P. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 234 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗